Reversible cerebral vasoconstriction syndrome developed during treatment of Parkinson's disease with rasagiline mesylate: A case report

• Main Authors: Akihiko Nakaya (Author), Kimihiko Kaneko (Author), Arifumi Matsumoto (Author), Yuki Matsumoto (Author), Yasuhiko Matsumori (Author), Isao Nagano (Author)
• Format: Book
• Published: SAGE Publishing, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Rasagiline mesylate, a monoamine oxidase-B inhibitor, is used in Parkinson's disease (PD) treatment. We report a case of reversible cerebral vasoconstriction syndrome (RCVS) developed after rasagiline mesylate initiation. Case presentation A 59-year-old woman was diagnosed with PD at...